mTORC1-Selective Activation of Translation Elongation Promotes Disease Progression in Chronic Lymphocytic Leukemia

Investigators highlighted the importance of translation elongation as a driver of disease progression and identified inactivation of eEF2 activity as a novel therapeutic target for blocking chronic lymphocytic leukemia progression.